Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.
Heart Vessels. 2022 Sep;37(9):1516-1525. doi: 10.1007/s00380-022-02063-6. Epub 2022 Mar 30.
Although glucose variability (GV) is reportedly associated with coronary plaque vulnerability, namely lipid-rich plaque, details are not fully understood. The aim of this study was to evaluate relations of GV after discharge to vulnerable plaque formation assessed by near-infrared spectroscopy intravascular ultrasound (NIRS-IVUS) in patients with and without diabetes.
A total of 40 patients undergoing percutaneous coronary intervention under NIRS-IVUS guidance were included, among whom 13 (33%) had diabetes and 20 (50%) presented with acute myocardial infarction (MI). GV was evaluated by a flush glucose monitoring system, primarily with mean amplitude of glycemic excursion (MAGE). Lipid-rich plaque was assessed by maximum lipid core burden index in 4 mm (maxLCBI) in the target lesion using NIRS-IVUS.
Mean MAGE and maxLCBI were 69.7 ± 25.6 mg/dl and 508.0 ± 294.9. Intra-day GV was not significantly associated with maxLCBI in the entire study population, while MAGE was correlated with maxLCBI in non-diabetic patients (r = 0.46, p = 0.02). In patients with and without acute MI presentation, no significant relations were found between MAGE and maxLCBI.
GV was associated with lipid core plaque formation, especially in non-diabetic patients.
尽管葡萄糖变异性(GV)与易损斑块(即富含脂质的斑块)有关,但具体细节尚不清楚。本研究旨在评估出院后 GV 与接受近红外光谱血管内超声(NIRS-IVUS)评估的糖尿病和非糖尿病患者易损斑块形成的关系。
共纳入 40 例行 NIRS-IVUS 引导下经皮冠状动脉介入治疗的患者,其中 13 例(33%)患有糖尿病,20 例(50%)发生急性心肌梗死(MI)。通过Flush 血糖监测系统主要用血糖波动幅度(MAGE)评估 GV。采用 NIRS-IVUS 在目标病变处评估最大脂质核心负荷指数(maxLCBI)评估富含脂质的斑块。
平均 MAGE 和 maxLCBI 分别为 69.7±25.6mg/dl 和 508.0±294.9。在整个研究人群中,日内 GV 与 maxLCBI 无显著相关性,而 MAGE 与非糖尿病患者的 maxLCBI 相关(r=0.46,p=0.02)。在有和无急性 MI 表现的患者中,MAGE 与 maxLCBI 之间未发现显著关系。
GV 与脂质核心斑块形成有关,尤其是在非糖尿病患者中。